Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accorda… (NCT06607042) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V
60 participantsStarted 2024-09-16
Plain-language summary
The main goal of this clinical trial is to learn if psychotherapy works to reduce consumption of child abuse imagages.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age at first presentation minimum 18 years
* Voluntary consent to participation on the part of the participant
* At the time of inclusion, no contact with the justice system (ongoing investigation, ongoing criminal proceedings, ongoing prison sentence) due to sexually abusive behavior towards children
* Sexually conspicuous behavior and/or fantasies or impulses that indicate the presence of a pedophilic and/or hebephilic preference disorder.
* An offer of treatment is made when a suspected diagnosis is confirmed or the diagnosis is confirmed
* Feared or recent use of abusive images
* Sufficient knowledge of German
* Voluntary participation in the study and checking the checkbox in the informed consent form before starting participation
Exclusion Criteria:
* Age under 18 years
* Lack of consent on the part of the patient
* Exclusion of the presence of a pedophilic and/or hebephilic preference disorder
* Current legal status in the sense of an ongoing investigation or criminal proceedings due to sexually assaultive behavior towards children
* Severe comorbidities: unstable psychotic disorder, organic brain damage, reduced intellectual capacity (IQ below 70), untreated drug or alcohol addiction or persistent harmful use
* Current risk of child sexual abuse and or child sexual abuse that occurred less than 15 years before the start of the study
* An antiandrogenic medication or an opiate antagonist, during therapy start taking a serotonin reuptake inhibit…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Abstinence
Timeframe: From enrollment to the end of treatment 12 - 18 weeks